BP p.l.c., an integrated energy company, provides carbon products and services. The company operates through Gas & Low Carbon Energy, Oil Production & Operations, and Customers & Products segments. It engages in the production of natural gas and integrated gas and power; gas trading; operation of solar and onshore and offshore wind power, as well as hydrogen and carbon capture, power trading, and storage facilities; trading and marketing of renewable and non-renewable power; and production of crude oil. The company is also involved in convenience and retail fuel, EV charging, Castrol lubricant, aviation, B2B, and midstream businesses; refining and oil trading; and bioenergy business. BP p.l.c. was founded in 1908 and is headquartered in London, the United Kingdom.

BP p.l.c.

Deutsche Bank analyst Richard Stuber reiterated a Buy rating on On The Beach today and set a price target of p345.00. Stuber covers the Consumer Cy...

Deutsche Bank  Sticks to Its Buy Rating for On The Beach (OTB)

BPH Energy Limited ( ($AU:BPH) ) has provided an announcement. BPH Energy Limited has reported the outcomes of its 9 April 2026 general meeting, co...

BPH Energy shareholders back all resolutions at April general meeting

Basilea Pharmaceutica ( ($CH:BSLN) ) has issued an announcement. Basilea Pharmaceutica has secured an additional USD 6 million in non‑dilutive fund...

Basilea Wins CARB-X Funding Boost for First-in-Human Trial of Novel Antibiotic BAL2420

Gas prices are a hot topic on Wednesday alongside falling oil prices due to a ceasefire agreement.


Are Gas Prices Down Today Following the Ceasefire Agreement?

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Corbus Pharmaceuticals (CRBP), Armata Pharmaceuticals (ARMP) and ...

Analysts Offer Insights on Healthcare Companies: Corbus Pharmaceuticals (CRBP), Armata Pharmaceuticals (ARMP) and Moderna (MRNA)

In a report released today, from Wedbush reiterated a Buy rating on Corbus Pharmaceuticals, with a price target of $38.00. In addition to Wedbush, ...

Corbus Pharmaceuticals (CRBP) Gets a Buy from Wedbush

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NovaBridge Biosciences (NBP) and Sanofi (SNYNF) with...

Analysts Offer Insights on Healthcare Companies: NovaBridge Biosciences (NBP) and Sanofi (OtherSNYNF)

NovaBridge Biosciences ( ($NBP) ) has issued an update. On April 7, 2026, NovaBridge Biosciences reported its full-year 2025 results, underscoring ...

NovaBridge Biosciences Highlights 2025 Results and Advances Late-Stage Oncology and Ophthalmology Programs

Pangea Natural Food, Inc. ( ($TSE:BPC) ) has issued an announcement. The Precision Peptide Company has launched a new corporate website that will p...

Precision Peptide Company Launches Website as U.S. Policy Shifts Boost Peptide Outlook

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on First Bancorp Puerto Rico (FBP) and Tradeweb Markets ...

Analysts Offer Insights on Financial Companies: First Bancorp Puerto Rico (FBP) and Tradeweb Markets (TW)

Protagenic Therapeutics ( ($PTIX) ) has shared an announcement. On March 31, 2026, Protagenic Therapeutics, Inc. disclosed that its Board of Direct...

Protagenic Therapeutics Announces Termination of Chief Financial Officer

In a report released today, from Ord Minnett upgraded Medibank Private to a Buy, with a price target of A$5.10. Medibank Private has an analyst con...

Positive Report for Medibank Private (MDBPF) from Ord Minnett

In a report released today, from Ord Minnett maintained a Hold rating on Beach Energy , with a price target of A$1.22. In addition to Ord Minnett, ...

Ord Minnett Sticks to Their Hold Rating for Beach Energy  (BEPTF)

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on ArriVent BioPharma, Inc., with a price target of $45.00. Accord...

JonesTrading Remains a Buy on ArriVent BioPharma, Inc. (AVBP)

BP Silver Corp. ( ($TSE:BPAG) ) has shared an announcement. BP Silver Corp. has closed the second tranche of its non‑brokered private placement, ra...

BP Silver Raises C$9.38 Million as Private Placement Nears Completion

Markets closed the week with a cautious tone as oil, rates, and risk all moved higher. The S&P 500 (SPX) reached 6,582, while the Nasdaq (NDX) and ...

The Week That Was, The Week Ahead: Macro and Markets, April 5

Broadpeak SA ( ($FR:ALBPK) ) just unveiled an update. Broadpeak has reported its latest share capital and voting rights structure, disclosing that ...

Broadpeak Updates Market on Share Capital and Voting Rights Structure

Kepler Capital analyst Ricky Botramamy maintained a Buy rating on Banco Comercial Portugues on April 2 and set a price target of €1.10. The company...

Kepler Capital  Sticks to Its Buy Rating for Banco Comercial Portugues (0RJN)

In a report released yesterday, Dana Telsey from Telsey Advisory maintained a Hold rating on H&M Hennes & Mauritz AB Class B, with a price target o...

H&M Hennes & Mauritz AB Class B (0HBP) Receives a Hold from Telsey Advisory

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B...

3 Best Stocks to Buy Today, 4/3/2026, According to Top Analysts

Gas prices have taken off ahead of the Easter holiday weekend as the U.S. prepares for travel.


Gas Prices Soar Heading Into the Easter Holiday Weekend

Banca Profilo SPA ( ($IT:PRO) ) has provided an announcement. Banca Profilo has made available the documentation for the extraordinary section of i...

Banca Profilo Publishes Documentation for Extraordinary Shareholders’ Meeting

In a report released today, Henry Tarr from Berenberg Bank maintained a Buy rating on BP p.l.c., with a price target of £7.00. Tarr covers the Ener...

Berenberg Bank Remains a Buy on BP p.l.c. (BP)

Macquarie analyst maintained a Sell rating on Beach Energy today and set a price target of A$0.77. In addition to Macquarie, Beach Energy also rece...

Macquarie Reaffirms Their Sell Rating on Beach Energy  (BEPTF)

The latest announcement is out from BP ( ($BP) ). As of 31 March 2026, BP reported an issued share capital of 15,700,880,610 ordinary shares with o...

BP Updates Total Voting Rights and Share Capital as of March 31, 2026

BP ( ($BP) ) has shared an announcement. In March 2026, BP reported several management share transactions and confirmed details of its fourth-quart...

BP details March 2026 insider share dealings and sets sterling payout for Q4 2025 dividend

Banca Profilo SPA ( ($IT:PRO) ) has provided an update. Banca Profilo has made its Annual Financial Report as of 31 December 2025 available to the ...

Banca Profilo Publishes 2025 Annual Report and Shareholders’ Meeting Documentation

In a report released yesterday, Lydia Rainforth from Barclays maintained a Buy rating on BP p.l.c.. The company’s shares closed today at p606.30. R...

Barclays Reaffirms Their Buy Rating on BP p.l.c. (BP)

Bridgepoint Group Plc ( ($GB:BPT) ) has shared an announcement. Bridgepoint Group plc reported that as of 31 March 2026, its issued share capital c...

Bridgepoint updates total voting rights and share capital structure

Mitchells & Butlers ( ($GB:MAB) ) has shared an announcement. Mitchells & Butlers has confirmed that as of 31 March 2026 its issued share capital c...

Mitchells & Butlers Confirms Share Capital and Voting Rights

B.P. Marsh & Partners plc ( ($GB:BPM) ) has shared an announcement. B.P. Marsh & Partners has continued to execute its previously announced share b...

B.P. Marsh Updates Voting Rights After Treasury Share Buyback

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Theravance Biopharma (TBPH) and Phreesia (PHR). Theravance Biopha...

Analysts Offer Insights on Healthcare Companies: Theravance Biopharma (TBPH) and Phreesia (PHR)

Stemcell United Ltd. ( ($AU:BP8) ) has provided an announcement. BPH Global Ltd says its seaweed-based bio-fertiliser and bio-stimulant R&D program...

BPH Global Nears Key R&D Milestone in Seaweed-Based Fertiliser Push

Theravance Biopharma ( ($TBPH) ) has shared an update. On March 27, 2026, Theravance and its partner Mylan reached a settlement with Mankind Pharma...

Theravance Secures Long-Term YUPELRI Patent Litigation Settlement

B.P. Marsh & Partners plc ( ($GB:BPM) ) has issued an announcement. B.P. Marsh & Partners Plc has disclosed that Chief Executive Officer Dan Toppin...

B.P. Marsh CEO Dan Topping Increases Stake with £25,000 Share Purchase

In a report released today, Timur Braziler from Wells Fargo maintained a Buy rating on First Bancorp Puerto Rico, with a price target of $24.00. Ac...

Wells Fargo Reaffirms Their Buy Rating on First Bancorp Puerto Rico (FBP)

Wells Fargo analyst Timur Braziler maintained a Buy rating on Popular today and set a price target of $163.00. According to TipRanks, Braziler is a...

Wells Fargo Sticks to Its Buy Rating for Popular (BPOP)

Kepler Capital analyst Erik Sandstedt maintained a Buy rating on H&M Hennes & Mauritz AB Class B on March 26 and set a price target of SEK200.00. T...

Kepler Capital  Reaffirms Their Buy Rating on H&M Hennes & Mauritz AB Class B (0HBP)

BP Silver Corp. ( ($TSE:BPAG) ) has shared an update. BP Silver Corp. has closed the initial tranche of its non-brokered private placement, raising...

BP Silver Upsizes Private Placement to C$10 Million After Strong Demand

CAB Payments Holdings Limited ( ($GB:CABP) ) has provided an announcement. CAB Payments’ independent board has rejected the Helios Consortium’s uns...

CAB Payments board rebuffs Helios bid as undervaluing company

In a report released today, Adam Cochrane from Deutsche Bank maintained a Hold rating on H&M Hennes & Mauritz AB Class B, with a price target of SE...

Deutsche Bank  Keeps Their Hold Rating on H&M Hennes & Mauritz AB Class B (0HBP)

In a report released today, Georgina Johanan from J.P. Morgan maintained a Sell rating on H&M Hennes & Mauritz AB Class B, with a price target of S...

J.P. Morgan Sticks to Their Sell Rating for H&M Hennes & Mauritz AB Class B (0HBP)

RBC Capital analyst Gerard Cassidy maintained a Buy rating on Popular yesterday and set a price target of $141.00. Cassidy covers the Financial sec...

Popular (BPOP) Receives a Buy from RBC Capital

The latest update is out from Biophytis ( ($BPTSY) ). Biophytis SA, a clinical-stage biotech focused on age-related diseases and longevity therapeu...

Biophytis Showcases AI-Driven Longevity Drug Discovery with LynxKite at NVIDIA GTC 2026

Barclays analyst Matthew Clements maintained a Sell rating on H&M Hennes & Mauritz AB Class B today and set a price target of SEK162.00. Clements c...

H&M Hennes & Mauritz AB Class B (0HBP) Receives a Sell from Barclays

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Theravance Biopharma (TBPH) and Denali Therapeutics ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

Macquarie analyst maintained a Hold rating on Medibank Private today and set a price target of A$4.80. Currently, the analyst consensus on Medibank...

Macquarie Sticks to Their Hold Rating for Medibank Private (MDBPF)

In a report released on March 23, Nikhil Bhandari from Goldman Sachs downgraded Bharat Petroleum Corporation Limited to a Hold, with a price target...

Goldman Sachs downgrades Bharat Petroleum Corporation Limited (BPCL) to a Hold

CAB Payments Holdings Limited ( ($GB:CABP) ) has issued an announcement. CAB Payments Holdings plc has granted performance share awards to several ...

CAB Payments Ties Executive Share Awards to Tough Profitability Targets

RBC Capital analyst Biraj Borkhataria maintained a Hold rating on BP p.l.c. on March 20 and set a price target of p640.00. The company’s shares clo...

BP p.l.c. (BP) Receives a Hold from RBC Capital

Bridgepoint Group Plc ( ($GB:BPT) ) just unveiled an update. Bridgepoint Group plc will issue 1,399,733 new ordinary shares to satisfy vesting awar...

Bridgepoint Issues New Shares to Satisfy LTIP Awards and Updates Voting Rights

Ord Minnett analyst maintained a Buy rating on Medibank Private today and set a price target of A$5.10. Currently, the analyst consensus on Mediban...

Ord Minnett Remains a Buy on Medibank Private (MDBPF)

BP p.l.c. received a Hold rating and a p565.00 price target from HSBC analyst Kim Fustier today. According to TipRanks, Fustier is a 4-star analyst...

HSBC upgrades BP p.l.c. (BP) to a Hold

BP Silver Corp. ( ($TSE:BPAG) ) has shared an announcement. BP Silver Corp. has begun trading its common shares on the U.S. OTCQB marketplace under...

BP Silver Lists on OTCQB and Accelerates Field Work at Bolivian Cosuño Project

On The Beach ( ($GB:OTB) ) has shared an announcement. On the Beach Group has announced that Chief Marketing Officer and Board director Zoe Harris ...

On the Beach CMO Zoe Harris to Step Down in May 2026

On The Beach ( ($GB:OTB) ) has provided an update. On the Beach Group plc reported that its Chief People Officer, Jennie Cronin, has exercised opti...

On the Beach Chief People Officer Sells Shares After Option Exercise

Medibank Private ( ($AU:MPL) ) just unveiled an announcement. Medibank has been ordered to hand over three Deloitte reports on its 2022 cybercrime ...

Medibank ordered to release Deloitte cybercrime reports in class action

In a report released on March 18, Erik Sandstedt from Kepler Capital maintained a Buy rating on H&M Hennes & Mauritz AB Class B, with a price targe...

H&M Hennes & Mauritz AB Class B (0HBP) Gets a Buy from Kepler Capital

An announcement from BPM Minerals Ltd. ( ($AU:BPM) ) is now available. BPM Minerals Ltd. has notified the market that 800,000 performance rights, q...

BPM Minerals lets 800,000 performance rights lapse, trimming potential dilution

The latest announcement is out from Banca Profilo SPA ( ($IT:PRO) ). Banca Profilo has received Banca d’Italia’s final decision on its consolidated...

Banca Profilo Reports Capital Ratios Well Above Supervisory Requirements

BPM Minerals Ltd. ( ($AU:BPM) ) has shared an update. BPM Minerals Limited has issued 45,000 fully paid ordinary shares following the conversion of...

BPM Minerals Issues New Shares Following Option Conversion

BPM Minerals Ltd. ( ($AU:BPM) ) just unveiled an announcement. BPM Minerals Ltd. has applied to the ASX for quotation of 45,000 additional ordinary...

BPM Minerals seeks ASX quotation for additional 45,000 shares

Stemcell United Ltd. ( ($AU:BP8) ) has issued an announcement. BPH Global has completed the final formulation of its proprietary seaweed-based men’...

BPH Global Finalises Men’s Health Supplement Formula, Moves Toward Efficacy Testing

On The Beach ( ($GB:OTB) ) has provided an update. On the Beach Group plc has disclosed that chief marketing officer Zoe Harris has exercised 423,9...

On the Beach CMO Exercises LTIP Options and Sells Shares to Cover Tax

J.P. Morgan analyst Matthew Lofting maintained a Hold rating on BP p.l.c. today and set a price target of £5.20. According to TipRanks, Lofting is ...

J.P. Morgan Reaffirms Their Hold Rating on BP p.l.c. (BP)

Barclays analyst Lydia Rainforth maintained a Buy rating on BP p.l.c. yesterday. The company’s shares closed yesterday at p551.90. According to Tip...

The latest announcement is out from BP Silver Corp. ( ($TSE:BPAG) ). BP Silver Corp., a Canadian silver exploration company focused on Bolivia’s pr...

BP Silver Launches C$8 Million Financing to Advance Bolivian Cosuño Silver Project

B.P. Marsh & Partners plc ( ($GB:BPM) ) has provided an update. B.P. Marsh & Partners has sold its 39.24% stake in Amiga Speciality Holdings, an in...

B.P. Marsh crystallises Amiga stake as Sodalis accelerates insurance buy-and-build

Stemcell United Ltd. ( ($AU:BP8) ) just unveiled an announcement. BPH Global Ltd. has expanded its seaweed biomass research program to pursue renew...

BPH Global targets seaweed-based biofuel as fermentation business nears commercial stage

Stemcell United Ltd. ( ($AU:BP8) ) has issued an update. BPH Global Limited has released an investor presentation outlining information about its s...

BPH Global outlines seaweed biotech positioning in investor briefing

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Esperion (ESPR – Research Report) and NovaBridge Bio...

Analysts’ Top Healthcare Picks: Esperion (ESPR), NovaBridge Biosciences (NBP)

CAB Payments Holdings Limited ( ($GB:CABP) ) has shared an update. CAB Payments has confirmed it received an unsolicited, non-binding cash proposal...

CAB Payments Evaluates Unsolicited Takeover Approach from StoneX

Bank of America Securities analyst Christopher Kuplent maintained a Sell rating on BP p.l.c. yesterday and set a price target of p400.00. The compa...

BP p.l.c. (BP) Receives a Sell from Bank of America Securities

JX Luxventure ( ($JXG) ) just unveiled an announcement. On March 13, 2026, JX Luxventure Group Inc. announced that director and audit committee mem...

JX Luxventure Appoints New Independent Director to Audit Committee After Board Resignation

Goldman Sachs analyst Michele Della Vigna maintained a Buy rating on BP p.l.c. today and set a price target of p590.00. Della Vigna covers the Ener...

BP p.l.c. (BP) Receives a Buy from Goldman Sachs

In a report released today, from Goldman Sachs maintained a Buy rating on BP, with a price target of $45.00. The word on The Street in general, sug...

Goldman Sachs Remains a Buy on BP (BP)

Shore Capital analyst reiterated a Hold rating on On The Beach yesterday. The company’s shares closed yesterday at p167.00. Currently, the analyst ...

On The Beach (OTB) Gets a Hold from Shore Capital

On The Beach ( ($GB:OTB) ) has provided an update. On the Beach Group plc reported that all resolutions at its Annual General Meeting on 12 March 2...

On the Beach wins full shareholder backing at 2026 AGM

Companies in the Energy sector have received a lot of coverage today as analysts weigh in on BP (BP – Research Report) and Schlumberger (SLB – Rese...

Analysts Have Conflicting Sentiments on These Energy Companies: BP (BP) and Schlumberger (SLB)

Biophytis ( ($BPTSY) ) has shared an update. On March 11, 2026, Biophytis announced it had raised €2.015 million in gross proceeds via a capital in...

Biophytis Raises €2 Million, Clears Convertible Debt to Fund Longevity Trials

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Medpace Holdings (MEDP – Research Report), Revolutio...

Current Quarter	$0.7	Next Quarter	$1
Current Year	$3.55	Next Year	$3.44
QoQ Growth	+42.9%	YoY Growth	-3.1%
3Y EPS CAGR	-31.5%	Target Price	$43.70
Consensus	Buy	Upside	-4.8%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BP	$45.89	0.00%	18.46M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BP	$45.89	0%	18.46M
3
4
5
6

BP

BP

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get BP p.l.c. Data in Excel

Get BP p.l.c. Data in Excel